Hydroxyurea (Biosupressin-BIOGAL) for the treatment of chronic myelogenous leukaemia.
作者信息
Klener P, Donner L
出版信息
Ther Hung. 1981;29(1):38-41.
PMID:6964902
Abstract
摘要
相似文献
1
Hydroxyurea (Biosupressin-BIOGAL) for the treatment of chronic myelogenous leukaemia.
Ther Hung. 1981;29(1):38-41.
2
Hydroxyurea as a cause of drug fever in chronic myeloid leukaemia.
Neth J Med. 1988 Jun;32(5-6):240-2.
3
[Effect of hydroxyurea treatment on free nucleotides in leukemic leukocytes].[羟基脲治疗对白血病白细胞中游离核苷酸的影响]
Acta Haematol Pol. 1975 Jul-Sep;6(3):211-6.
4
[Experiences in the treatment of chronic myeloid leukemia].[慢性髓性白血病的治疗经验]
Haematologica. 1971;56(3):163-8.
5
Clinical trial of hydroxyurea in chronic myelocytic leukemia.
Haematol Lat. 1967 Oct-Dec;10(4):359-62.
6
[Treatment of chronic myeloid leukemia with hydroxyurea].[羟基脲治疗慢性粒细胞白血病]
Harefuah. 1971 Nov 1;81(9):438-41.
7
[Chronic myeloid leukaemia. Clinical study and analysis of therapeutical results in 55 cases].
Sangre (Barc). 1982;27(4A):493-507.
8
9
[Hydroxyurea in the treatment of chronic myeloid leukemia].
Haematol Lat. 1969 Jul-Dec;12(3):767-70.
10
[The use of hydroxyurea (Biosuppressin) in the accelerated phase of chronic myeloid leukemia].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(2):275-80.
Zotero 插件